ALPS Medical Breakthroughs ETF
SS&C Technologies Holdings, Inc. SBIO ETF
| SBIO Price | $30.07 |
Market Cap | $81.2M |
| Annual Dividend Yield | 3.86% |
Annual Dividend | $1.17 |
| Yearly Management Fee | 0.50% |
Asset Class | Equity |
| Focus | Health care |
Category | Sector, Health Care |
| Niche | Biotechnology |
Last 24h Volume | $225.99K |
| Portfolio Management Company | SS&C Technologies Holdings, Inc. |
Discount/Premium to NAV | -0.07% |
| Inception Date | Dec 31, 2014 |
Market Cap Rank | 2326 |
| Monthly AUM Growth | 1.74% |
Holdings Region | North America |
| Management Style | Passive |
Leverage | Non-Leveraged |
ALPS Medical Breakthroughs ETF is an ETF issued by SS&C Technologies Holdings, Inc. on Dec 31 2014.
The main focus of this ETF, which is in the "Equity" asset class, is determined as "Health care".
As of today, the price of SBIO ETF according to its net asset value is discounted at -0.07%.
While the total value of the fund shows $1.39M increase compared to the previous month, its price is traded daily at a decrease of -0.92%.
The annual dividend yield of SBIO ETF is 3.86%, whereas its main asset area is North America.
SBIO ETF, whose 24-hour total volume is $225.99K, has experienced a $-5,397,000 cash outflow in the last month.
In addition, ALPS Medical Breakthroughs ETF's 3-month net asset value total return is 2.46%.
SBIO ETF Returns
| Daily |
Weekly |
Monthly |
3 Mo |
6 Mo |
YTD |
Yearly |
| -0.92% |
0.84% |
3.90% |
5.73% |
-9.62% |
-9.37% |
-10.24% |
SBIO ETF NAV Total Return
| Monthly |
3 Mo |
YTD |
Yearly |
3 Years |
5 Years |
| 5.89% |
2.46% |
-8.39% |
-4.20% |
12.87% |
-24.68% |
SBIO ETF Fund Flows Chart
SBIO ETF Market Cap Chart
SBIO ETF NAV Growth Chart
SBIO ETF Comments
no comments yet